BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33549033)

  • 1. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
    Takiar V; Fontanilla HP; Eifel PJ; Jhingran A; Kelly P; Iyer RB; Levenback CF; Zhang Y; Dong L; Klopp A
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1045-50. PubMed ID: 23332221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor and metastatic lymph nodes metabolic activity on
    Song J; Pang W; Yi H; Ji J; Ye X; Li L
    Abdom Radiol (NY); 2024 Mar; 49(3):975-984. PubMed ID: 38302763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement.
    Brooks FJ; Grigsby PW
    Radiat Oncol; 2013 Dec; 8():294. PubMed ID: 24365202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
    J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Additional Role of F18-FDG PET/CT in Characterizing MRI-Diagnosed Tumor Deposits in Locally Advanced Rectal Cancer.
    Roef MJ; van den Berg K; Rutten HJT; Burger J; Nederend J
    Tomography; 2024 Apr; 10(4):632-642. PubMed ID: 38668405
    [No Abstract]   [Full Text] [Related]  

  • 9. MRI morphological characteristics of lymph nodes in anal squamous cell carcinoma.
    Gulevski S; Frennered A; Trägårdh E; Nilsson MP; Johnsson A; Buchwald P; Blomqvist L; Zackrisson S
    Abdom Radiol (NY); 2024 Apr; 49(4):1042-1050. PubMed ID: 38319345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
    Del M; Illac C; Morisseau M; Angeles MA; Ducassou A; Betrian S; Bataillon G; Ferron G; Chantalat E; Gabiache E; Martinez A
    Int J Gynecol Cancer; 2024 Apr; 34(4):490-496. PubMed ID: 38471676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial.
    Tax C; Abbink K; Rovers MM; Bekkers RLM; Zusterzeel PLM
    Pilot Feasibility Stud; 2018; 4():27. PubMed ID: 29318031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
    Braun C; Grünig H; Peikert J; Strobel K; Christmann-Schmid C; Brambs C
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():13-19. PubMed ID: 38394714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy in the initial nodal staging of rectal cancer (MRI or PET/CT?).
    López Llobet E; Coronado Poggio M; Lancha Hernández C; Martín Hervás C; Travaglio Morales D; Monachello Araujo D; Rodado Marina S; Domínguez Gadea L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500004. PubMed ID: 38527730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
    Nitecki R; Ramirez PT; Dundr P; Nemejcova K; Ribeiro R; Vieira Gomes MT; Schmidt RL; Bedoya L; Isla DO; Pareja R; Rendón Pereira GJ; Lopez A; Kushner D; Cibula D
    Int J Gynecol Cancer; 2023 Nov; 33(11):1684-1689. PubMed ID: 37652529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of positron emission tomography with computed tomography examination with histopathological assessment of pelvic lymph nodes in patients with cervical cancer treated surgically.
    Kaźmierczak K; Cholewiński W; Nowakowski B
    Contemp Oncol (Pozn); 2021; 25(3):160-167. PubMed ID: 34729035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factor-based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix.
    Liu FY; Chen WC; Pan YB; Wang CC; Tang YH; Chou HH; Chao A; Yang LY; Lai CH
    Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38192162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy.
    Lucia F; Bourbonne V; Gujral D; Dissaux G; Miranda O; Mauguen M; Pradier O; Abgral R; Schick U
    Clin Transl Radiat Oncol; 2020 Jul; 23():50-59. PubMed ID: 32435702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?
    Bebia V; Díaz-Feijoo B; Tejerizo Á; Torne A; Benito V; Hernández A; Gorostidi M; Domingo S; Bradbury M; Luna-Guibourg R; Gil-Moreno A;
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Baseline
    Lucia F; Miranda O; Abgral R; Bourbonne V; Dissaux G; Pradier O; Hatt M; Schick U
    Front Oncol; 2020; 10():678. PubMed ID: 32457839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.